Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-28

Clinical Trial Update: Effect of Itopride on Semaglutide Gastroparesis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether Itopride improves gastroparesis symptoms in patients with semaglutide-induced gastric motility issues; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • itopride (itopride)
  • semaglutide (semaglutide)

Snippet

Sponsor: Ain Shams University | Conditions: Semaglutide-Induced Gastric Motility, Anesthesia | Phase 4 | Status: RECRUITING